Cargando…
Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome
BACKGROUND: Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a genetically heterogeneous disorder caused by mitochondrial DNA (mtDNA) mutations in the MT-TL1 gene. The pathophysiology of neurological manifestations is still unclear, but neuronal hyperexc...
Autores principales: | Guerrero-Molina, María Paz, Morales-Conejo, Montserrat, Delmiro, Aitor, Morán, María, Domínguez-González, Cristina, Arranz-Canales, Elena, Ramos-González, Ana, Arenas, Joaquín, Martín, Miguel A., González de la Aleja, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794606/ https://www.ncbi.nlm.nih.gov/pubmed/35088140 http://dx.doi.org/10.1007/s00415-021-10942-7 |
Ejemplares similares
-
Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
por: Madeira, Caroline, et al.
Publicado: (2018) -
Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients
por: Hashimoto, Kenji, et al.
Publicado: (2005) -
Clinical, genetic and quality-of-life study of a cohort of adult patients with tuberous sclerosis
por: De Sautu De Borbón, Elena Cristina, et al.
Publicado: (2021) -
Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders
por: Peñas, Ana, et al.
Publicado: (2021) -
Modeling the glutamate–glutamine neurotransmitter cycle
por: Shen, Jun
Publicado: (2013)